SG11201507763RA - 5-amino-quinoline-8-carboxamide derivatives as 5-ht4 receptor agonists - Google Patents
5-amino-quinoline-8-carboxamide derivatives as 5-ht4 receptor agonistsInfo
- Publication number
- SG11201507763RA SG11201507763RA SG11201507763RA SG11201507763RA SG11201507763RA SG 11201507763R A SG11201507763R A SG 11201507763RA SG 11201507763R A SG11201507763R A SG 11201507763RA SG 11201507763R A SG11201507763R A SG 11201507763RA SG 11201507763R A SG11201507763R A SG 11201507763RA
- Authority
- SG
- Singapore
- Prior art keywords
- quinoline
- amino
- receptor agonists
- carboxamide derivatives
- carboxamide
- Prior art date
Links
- 108091005482 5-HT4 receptors Proteins 0.000 title 1
- RPMSTHVPCJNFMM-UHFFFAOYSA-N 5-aminoquinoline-8-carboxamide Chemical class C1=CN=C2C(C(=O)N)=CC=C(N)C2=C1 RPMSTHVPCJNFMM-UHFFFAOYSA-N 0.000 title 1
- 239000000018 receptor agonist Substances 0.000 title 1
- 229940044601 receptor agonist Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57426—Specifically defined cancers leukemia
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/82—Translation products from oncogenes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Epidemiology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1199CH2013 IN2013CH01199A (enExample) | 2013-03-20 | 2013-10-18 | |
| PCT/IN2013/000639 WO2014147636A1 (en) | 2013-03-20 | 2013-10-18 | 5-amino-quinoline-8-carboxamide derivatives as 5-ht4 receptor agonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201507763RA true SG11201507763RA (en) | 2015-10-29 |
Family
ID=54325095
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201507763RA SG11201507763RA (en) | 2013-03-20 | 2013-10-18 | 5-amino-quinoline-8-carboxamide derivatives as 5-ht4 receptor agonists |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US9790211B2 (enExample) |
| EP (1) | EP2976337B1 (enExample) |
| JP (1) | JP6185650B2 (enExample) |
| KR (1) | KR101815307B1 (enExample) |
| CN (1) | CN105164119B (enExample) |
| AP (1) | AP2015008742A0 (enExample) |
| AU (1) | AU2013382944B2 (enExample) |
| BR (1) | BR112015024060A2 (enExample) |
| CA (1) | CA2907620C (enExample) |
| DK (1) | DK2976337T3 (enExample) |
| EA (1) | EA029365B1 (enExample) |
| ES (1) | ES2674993T3 (enExample) |
| IN (1) | IN2013CH01199A (enExample) |
| MX (1) | MX364929B (enExample) |
| NZ (1) | NZ712369A (enExample) |
| SG (1) | SG11201507763RA (enExample) |
| WO (1) | WO2014147636A1 (enExample) |
| ZA (1) | ZA201506804B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107406434B (zh) * | 2015-02-13 | 2020-09-11 | 苏文生命科学有限公司 | 作为5-ht4受体激动剂的酰胺化合物 |
| CN109444301A (zh) * | 2018-12-18 | 2019-03-08 | 江苏省中医院 | 一种测定血浆中普芦卡必利浓度的方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2146930A1 (en) * | 1992-10-13 | 1994-04-28 | Francis David King | Heterocyclic -esters or -amides used as 5-ht4 receptor antagonists |
| US5705498A (en) | 1992-11-05 | 1998-01-06 | Smithkline Beecham Plc. | Piperidine derivatives as 5-HT4 receptor antagonists |
| FR2756564B1 (fr) * | 1996-12-04 | 2004-05-14 | Synthelabo | Derives d'acide quinoleine-8-carboxylique, leur preparation et leur application en therapeutique |
| AU2001225664A1 (en) * | 2000-06-15 | 2001-12-24 | Respiratorius Ab | 5-ht3 receptor antagonists for treatment of disorders involving airway constriction |
| ATE373651T1 (de) * | 2003-06-19 | 2007-10-15 | Janssen Pharmaceutica Nv | 4-(aminomethyl)-piperidinbenzamide als 5ht4- antagonisten |
| EP1689742B1 (en) | 2003-11-24 | 2010-03-17 | Pfizer, Inc. | Quinolonecarboxylic acid compounds having 5-ht4 receptor agonistic activity |
| ES2340855T3 (es) | 2003-12-23 | 2010-06-10 | Serodus As | Modulares de receptores 5-ht perifericos. |
| WO2005092882A1 (en) | 2004-03-01 | 2005-10-06 | Pfizer Japan, Inc. | 4-amino-5-halogeno-benzamide derivatives as 5-ht4 receptor agonists for the treatment of gastrointestinal, cns, neurological and cardiovascular disorders |
| JP4970290B2 (ja) | 2005-02-25 | 2012-07-04 | ファイザー株式会社 | ベンズイソキサゾール誘導体 |
| JP5075818B2 (ja) | 2005-07-22 | 2012-11-21 | ファイザー株式会社 | ５ｈｔ４受容体アゴニストとしてのインダゾールカルボキサミド誘導体 |
| GB0525661D0 (en) * | 2005-12-16 | 2006-01-25 | Glaxo Group Ltd | Novel compounds |
| WO2011099305A1 (en) | 2010-02-12 | 2011-08-18 | Raqualia Pharma Inc. | 5-ht4 receptor agonists for the treatment of dementia |
| AU2011216950A1 (en) | 2010-02-16 | 2012-08-23 | Pfizer Inc. | (R)-4-((4-((4-(tetrahydrofuran-3-yloxy) benzo[d]isoxazol-3-yloxy)methyl)piperidin-1-yl)methyl)tetrahydro-2H-pyran-4-ol, a partial agonist of 5-HT4 receptors |
-
2013
- 2013-10-18 MX MX2015012350A patent/MX364929B/es active IP Right Grant
- 2013-10-18 JP JP2016504852A patent/JP6185650B2/ja not_active Expired - Fee Related
- 2013-10-18 AP AP2015008742A patent/AP2015008742A0/xx unknown
- 2013-10-18 AU AU2013382944A patent/AU2013382944B2/en not_active Ceased
- 2013-10-18 BR BR112015024060A patent/BR112015024060A2/pt not_active IP Right Cessation
- 2013-10-18 KR KR1020157030158A patent/KR101815307B1/ko not_active Expired - Fee Related
- 2013-10-18 WO PCT/IN2013/000639 patent/WO2014147636A1/en not_active Ceased
- 2013-10-18 NZ NZ712369A patent/NZ712369A/en not_active IP Right Cessation
- 2013-10-18 SG SG11201507763RA patent/SG11201507763RA/en unknown
- 2013-10-18 EP EP13811624.9A patent/EP2976337B1/en active Active
- 2013-10-18 CN CN201380074877.9A patent/CN105164119B/zh not_active Expired - Fee Related
- 2013-10-18 CA CA2907620A patent/CA2907620C/en not_active Expired - Fee Related
- 2013-10-18 EA EA201591844A patent/EA029365B1/ru not_active IP Right Cessation
- 2013-10-18 ES ES13811624.9T patent/ES2674993T3/es active Active
- 2013-10-18 US US14/777,925 patent/US9790211B2/en not_active Expired - Fee Related
- 2013-10-18 DK DK13811624.9T patent/DK2976337T3/en active
- 2013-10-18 IN IN1199CH2013 patent/IN2013CH01199A/en unknown
-
2015
- 2015-09-14 ZA ZA2015/06804A patent/ZA201506804B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA201591844A1 (ru) | 2016-08-31 |
| BR112015024060A2 (pt) | 2017-07-18 |
| ZA201506804B (en) | 2016-07-27 |
| CN105164119B (zh) | 2017-12-08 |
| AU2013382944A1 (en) | 2015-10-08 |
| MX364929B (es) | 2019-05-14 |
| WO2014147636A1 (en) | 2014-09-25 |
| EP2976337B1 (en) | 2018-05-02 |
| US20160280694A1 (en) | 2016-09-29 |
| KR101815307B1 (ko) | 2018-01-04 |
| WO2014147636A8 (en) | 2014-12-04 |
| AP2015008742A0 (en) | 2015-09-30 |
| MX2015012350A (es) | 2016-05-09 |
| CA2907620C (en) | 2018-03-13 |
| JP6185650B2 (ja) | 2017-08-23 |
| CA2907620A1 (en) | 2014-09-25 |
| IN2013CH01199A (enExample) | 2015-08-14 |
| US9790211B2 (en) | 2017-10-17 |
| NZ712369A (en) | 2016-11-25 |
| DK2976337T3 (en) | 2018-07-16 |
| EA029365B1 (ru) | 2018-03-30 |
| KR20160004274A (ko) | 2016-01-12 |
| HK1217483A1 (zh) | 2017-01-13 |
| ES2674993T3 (es) | 2018-07-05 |
| CN105164119A (zh) | 2015-12-16 |
| AU2013382944B2 (en) | 2016-08-04 |
| EP2976337A1 (en) | 2016-01-27 |
| JP2016516089A (ja) | 2016-06-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL240863A0 (en) | Amatoxin derivatives | |
| SG11201506100XA (en) | Pyridazinone-amides derivatives | |
| IL244609A0 (en) | History of 4-azaindole | |
| ZA201601333B (en) | Oxoquinazolinyl-butanamide derivatives | |
| IL242160B (en) | Purine derivatives as 2cb receptor agonists | |
| IL244039B (en) | Ethynyl derivatives | |
| SG11201605189YA (en) | Imidazopyrazinone derivatives | |
| IL245948A0 (en) | 5-ht4 indazole compounds as receptor agonists | |
| ZA201506804B (en) | 5-amino-quinoline-8-carboxamide derivatives as 5-ht4 receptor agonists | |
| IL243730A0 (en) | Vasopressin-2 receptor agonists | |
| GB201312010D0 (en) | Receptor Agonists | |
| GB201314960D0 (en) | Heterocyclic derivatives | |
| GB201300306D0 (en) | Heterocyclic derivatives | |
| GB201314961D0 (en) | Spirocyclic derivatives | |
| GB201314965D0 (en) | Spirocyclic derivatives |